Literature DB >> 22188235

Human ABCC1 interacts and colocalizes with ATP synthase α, revealed by interactive proteomics analysis.

Youyun Yang1, Zhaomin Li, Wei Mo, Raghuram Ambadipudi, Randy J Arnold, Petra Hrncirova, Milos V Novotny, Elias Georges, Jian-Ting Zhang.   

Abstract

Human ABCC1 is a member of the ATP-binding cassette (ABC) transporter superfamily, and its overexpression has been shown to cause multidrug resistance by active efflux of a wide variety of anticancer drugs. ABCC1 has been shown to exist and possibly function as a homodimer. However, a possible heterocomplex involving ABCC1 has been indicated. In this study, we performed an interactive proteomics study to examine proteins that bind to and form heterocomplexes with ABCC1 using coimmunoprecipitation and tandem mass spectrometry (MS/MS) analyses. We found that ATP synthase α binds to ABCC1 in plasma membranes with a ratio of 2:1. The ATP synthase α binding site in ABCC1 is located in the linker domain at the carboxyl core of ABCC1, and phosphorylation of the linker domain at the protein kinase A site enhances ATP synthase α binding. The interaction between ABCC1 and ATP synthase α in a heterocomplex may indicate a novel function of ABCC1 in regulating extracellular ATP level and purinergic signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22188235      PMCID: PMC8283941          DOI: 10.1021/pr201003g

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  21 in total

1.  Angiostatin binds ATP synthase on the surface of human endothelial cells.

Authors:  T L Moser; M S Stack; I Asplin; J J Enghild; P Højrup; L Everitt; S Hubchak; H W Schnaper; S V Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 2.  The mechanism of action of angiostatin: can you teach an old dog new tricks?

Authors:  Tammy L Moser; M Sharon Stack; Miriam L Wahl; Salvatore V Pizzo
Journal:  Thromb Haemost       Date:  2002-03       Impact factor: 5.249

Review 3.  Cell surface F1Fo ATP synthase: a new paradigm?

Authors:  Sulene L Chi; Salvatore V Pizzo
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

Review 4.  Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity.

Authors:  Jian-Ting Zhang
Journal:  Cell Res       Date:  2007-04       Impact factor: 25.617

5.  Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis.

Authors:  Zizheng Dong; Randy J Arnold; Youyun Yang; Myung Hee Park; Petra Hrncirova; Yehia Mechref; Milos V Novotny; Jian-Ting Zhang
Journal:  Mol Cell Proteomics       Date:  2005-04-25       Impact factor: 5.911

Review 6.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

7.  Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling.

Authors:  Yang Liu; Qun Chen; Jian-Ting Zhang
Journal:  J Proteome Res       Date:  2004 Jul-Aug       Impact factor: 4.466

8.  Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.

Authors:  Yang Liu; Hailan Liu; Baoguang Han; Jian-Ting Zhang
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

Review 9.  Relationship between drugs and functional activity of various mammalian P-glycoproteins (ABCB1).

Authors:  In-Wha Kim; Catherine Booth-Genthe; Suresh V Ambudkar
Journal:  Mini Rev Med Chem       Date:  2008-03       Impact factor: 3.862

10.  Cytoplasmic retraction of the amino terminus of human multidrug resistance protein 1.

Authors:  Qun Chen; Youyun Yang; Yang Liu; Baoguang Han; Jian-Ting Zhang
Journal:  Biochemistry       Date:  2002-07-23       Impact factor: 3.162

View more
  7 in total

Review 1.  Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer.

Authors:  Luksana Chaiswing; William H St Clair; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2018-02-21       Impact factor: 8.401

2.  Different roles of TM5, TM6, and ECL3 in the oligomerization and function of human ABCG2.

Authors:  Wei Mo; Jing Qi; Jian-Ting Zhang
Journal:  Biochemistry       Date:  2012-04-19       Impact factor: 3.162

3.  Spectrin domain of eukaryotic initiation factor 3a is the docking site for formation of the a:b:i:g subcomplex.

Authors:  Zizheng Dong; Jing Qi; Hui Peng; Jianguo Liu; Jian-Ting Zhang
Journal:  J Biol Chem       Date:  2013-08-06       Impact factor: 5.157

4.  Translational regulation of Chk1 expression by eIF3a via interaction with the RNA-binding protein HuR.

Authors:  Zizheng Dong; Jianguo Liu; Jian-Ting Zhang
Journal:  Biochem J       Date:  2020-05-29       Impact factor: 3.857

Review 5.  Linker Domains: Why ABC Transporters 'Live in Fragments no Longer'.

Authors:  Robert C Ford; Dominic Marshall-Sabey; John Schuetz
Journal:  Trends Biochem Sci       Date:  2019-12-12       Impact factor: 13.807

Review 6.  Cancer drug resistance: redox resetting renders a way.

Authors:  Yuan Liu; Qifu Li; Li Zhou; Na Xie; Edouard C Nice; Haiyuan Zhang; Canhua Huang; Yunlong Lei
Journal:  Oncotarget       Date:  2016-07-05

7.  14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression.

Authors:  Li Qin; Zizheng Dong; Jian-Ting Zhang
Journal:  Oncotarget       Date:  2016-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.